Multicenter Trial Management Unit Expands the Scope of Research at Yale
In the past, Yale investigators who led multicenter trials had to put together ad hoc study teams, relying on unconnected siloed services to carry out their research. At the end of these trials, these teams, which had compiled so much experience and knowledge, disbanded and their knowledge was lost. This system was inefficient and put Yale at a disadvantage when competing with other institutions for grants for multicenter studies.
Elena Gracheva is a finalist of the 2020 Blavatnik National Awards for Young Scientists
Dr. Elena Gracheva, an Associate Professor of Cellular & Molecular Physiology and of Neuroscience, is a 2020 Finalists of the prestigious Blavatnik National Awards for Young Scientists, the world’s largest unrestricted prize for early-career scientists.Source: Elena Gracheva is a finalist of the 2020 Blavatnik National Awards for Young Scientists
Minimizing blood vessel blockage
All cardiac procedures carry a risk of stroke because plaque or calcium buildup can break off in small pieces, ﬂoat up into the brain, and block narrow blood vessels. A highly specialized tool called an embolic protection device is currently used to prevent some of the released debris from reaching the brain.
Yale Medicine Surgeons Use 3D Printing to Benefit Patients
Some Yale Medicine surgeons now routinely use 3D printing (essentially producing a solid, three-dimensional object from a virtual digital model) to plan surgeries, design tools specific to an upcoming surgery and that particular patient’s anatomy, and even to print some of the parts used to replace defective ones in the body.Source: Yale Medicine
TAVR Is Helping People Avoid Open Heart Surgery
Use of TAVR means patients spend fewer days in the hospital and are able to return to their normal lives far more quickly. Yale Medicine is expected to do 300 of the procedures this year at Bridgeport and Yale New Haven hospitals, and Yale cardiologists have been at the forefront of TAVR research in general since the procedure became available in the mid-2000s.Source: Yale Medicine
Transvaginal Mesh: What Women Should Know
The Food and Drug Administration (FDA) recently halted sales of surgical mesh devices used for transvaginal repair of pelvic organ prolapse (POP). The FDA’s move, Yale Medicine specialists say, has left some women confused and concerned—especially since there are several types of surgery used to treat pelvic organ prolapse, and the FDA decision affects just one approach—a transvaginal mesh procedure.Source: Yale Medicine
Experts explain how millennials can take care of their unique health needs
"You've got your whole life ahead of you," young adults are often told—but that's of little comfort to the many 20- and 30-somethings who face "adulting" challenges like career uncertainty, overwhelming student loan debt, and relationship difficulties.Source: Medical XPress